MediZine taps Martin as creative director

Share this article:
MediZine has hired veteran creative Renee Martin as creative director marketing, art.

“With our company growing we needed a much more sophisticated art-oriented person to join our team,” said Alison Jaret, MediZine VP marketing & custom solutions. “We are in the point-of-care category, sometimes we have such slim differences that it is really hard to communicate without overlapping. Renee is helping us make that distinction with advertisers and helping them better understand how to use us.”

Martin previously served as the marketing art director at Smithsonian Publishing, working on Smithsonian and Air & Space magazines.

Martin told MM&M conveying the marketing message at MediZine is different and ultimately more rewarding than in the consumer category.

“This category is extremely important,” Martin said. “In the end I will be helping consumers educate themselves regarding conditions and the products available to them. It makes me feel that I’m going to be doing good for people.”

Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...